{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:04Z","timestamp":1791608164653,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Axonal regeneration in the adult mammalian central nervous system is limited in part by the non-permissive environment, including axonal growth inhibitors such as the Nogo-A protein. How the functions of these inhibitors can be blocked remains unclear. Here, we examined the role of LOTUS, an endogenous Nogo receptor antagonist, in promoting functional recovery and neural repair after spinal cord injury (SCI), as well as axonal regeneration after optic nerve crush. Wild-type untreated mice show incomplete but substantial intrinsic motor recovery after SCI. The genetic deletion of LOTUS delays and decreases the extent of motor recovery, suggesting that LOTUS is required for spontaneous neural repair. The neuronal overexpression of LOTUS in transgenic mice promotes motor recovery after SCI, and recombinant viral overexpression of LOTUS enhances retinal ganglion cell axonal regeneration after optic nerve crush. Thus, the level of LOTUS function titrates axonal regeneration.<\/jats:p>","DOI":"10.1038\/s41598-017-12449-6","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T13:51:22Z","timestamp":1505483482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS"],"prefix":"10.1038","volume":"7","author":[{"given":"Tomoko","family":"Hirokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Goshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-3092","authenticated-orcid":false,"given":"Stephen M.","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6938-0812","authenticated-orcid":false,"given":"Kohtaro","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"12449_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrn2936","volume":"11","author":"ME Schwab","year":"2010","unstructured":"Schwab, M. E. Functions of Nogo proteins and their receptors in the nervous system. Nat. Rev. Neurosci. \n                           11, 799\u2013811 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"12449_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrn1956","volume":"7","author":"G Yiu","year":"2006","unstructured":"Yiu, G. & He, Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. \n                           7, 617\u2013627 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"12449_CR3","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/35000226","volume":"403","author":"T GrandPr\u00e9","year":"2000","unstructured":"GrandPr\u00e9, T., Nakamura, F., Vartanian, T. & Strittmatter, S. M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature \n                           403, 439\u2013444 (2000).","journal-title":"Nature"},{"key":"12449_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0896-6273(94)90247-X","volume":"13","author":"L McKerracher","year":"1994","unstructured":"McKerracher, L. et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron \n                           13, 805\u2013811 (1994).","journal-title":"Neuron"},{"key":"12449_CR5","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nature00867","volume":"417","author":"KC Wang","year":"2002","unstructured":"Wang, K. C. et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature \n                           417, 941\u2013944 (2002).","journal-title":"Nature"},{"key":"12449_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/416636a","volume":"416","author":"EJ Bradbury","year":"2002","unstructured":"Bradbury, E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature \n                           416, 636\u201340 (2002).","journal-title":"Nature"},{"key":"12449_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrn1326","volume":"5","author":"J Silver","year":"2004","unstructured":"Silver, J. & Miller, J. H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. \n                           5, 146\u2013156 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"12449_CR8","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1523\/JNEUROSCI.5040-08.2009","volume":"29","author":"L Zhang","year":"2009","unstructured":"Zhang, L. et al. Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor. J. Neurosci. \n                           29, 6348\u20136352 (2009).","journal-title":"J. Neurosci."},{"key":"12449_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35053072","volume":"409","author":"aE Fournier","year":"2001","unstructured":"Fournier, aE., GrandPre, T. & Strittmatter, S. M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature \n                           409, 341\u2013346 (2001).","journal-title":"Nature"},{"key":"12449_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0896-6273(02)00770-5","volume":"35","author":"M Domeniconi","year":"2002","unstructured":"Domeniconi, M. et al. Myelin-Associated Glycoprotein Interacts with the Nogo66 Receptor to Inhibit Neurite Outgrowth. Neuron \n                           35, 283\u2013290 (2002).","journal-title":"Neuron"},{"key":"12449_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nn.3070","volume":"15","author":"TL Dickendesher","year":"2012","unstructured":"Dickendesher, T. L. et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Neurosci. \n                           15, 703\u201312 (2012).","journal-title":"Nat. Neurosci."},{"key":"12449_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nn1188","volume":"7","author":"S Mi","year":"2004","unstructured":"Mi, S. et al. LINGO-1 is a component of the Nogo-66 receptor\/p75 signaling complex. Nat. Neurosci. \n                           7, 221\u2013228 (2004).","journal-title":"Nat. Neurosci."},{"key":"12449_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1083\/jcb.200202010","volume":"157","author":"T Yamashita","year":"2002","unstructured":"Yamashita, T., Higuchi, H. & Tohyama, M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. \n                           157, 565\u2013570 (2002).","journal-title":"J. Cell Biol."},{"key":"12449_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuron.2004.12.040","volume":"45","author":"JB Park","year":"2005","unstructured":"Park, J. B. et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron \n                           45, 345\u2013351 (2005).","journal-title":"Neuron"},{"key":"12449_CR15","doi-asserted-by":"crossref","first-page":"10368","DOI":"10.1523\/JNEUROSCI.22-23-10368.2002","volume":"22","author":"B Nieder\u00f6st","year":"2002","unstructured":"Nieder\u00f6st, B., Oertle, T., Fritsche, J., McKinney, R. A. & Bandtlow, C. E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. \n                           22, 10368\u201310376 (2002).","journal-title":"J. Neurosci."},{"key":"12449_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/417547a","volume":"417","author":"T GrandPr\u00e9","year":"2002","unstructured":"GrandPr\u00e9, T., Li, S. & Strittmatter, S. M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature \n                           417, 547\u2013551 (2002).","journal-title":"Nature"},{"key":"12449_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2004.10.015","volume":"44","author":"JE Kim","year":"2004","unstructured":"Kim, J. E., Liu, B. P., Park, J. H. & Strittmatter, S. M. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron \n                           44, 439\u2013451 (2004).","journal-title":"Neuron"},{"key":"12449_CR18","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.22-20-08876.2002","volume":"22","author":"AE Fournier","year":"2002","unstructured":"Fournier, A. E., Gould, G. C., Liu, B. P. & Strittmatter, S. M. Truncated Soluble Nogo Receptor Binds Nogo-66 and Blocks Inhibition of Axon Growth by Myelin. J. Neurosci. \n                           22, 8876\u20138883 (2002).","journal-title":"J. Neurosci."},{"key":"12449_CR19","doi-asserted-by":"publisher","first-page":"10511","DOI":"10.1523\/JNEUROSCI.2828-04.2004","volume":"24","author":"S Li","year":"2004","unstructured":"Li, S. Blockade of Nogo-66, Myelin-Associated Glycoprotein, and Oligodendrocyte Myelin Glycoprotein by Soluble Nogo-66 Receptor Promotes Axonal Sprouting and Recovery after Spinal Injury. J. Neurosci. \n                           24, 10511\u201310520 (2004).","journal-title":"J. Neurosci."},{"key":"12449_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/ana.20953","volume":"60","author":"X Wang","year":"2006","unstructured":"Wang, X., Baughman, K. W., Basso, D. M. & Strittmatter, S. M. Delayed nogo receptor therapy improves recovery from spinal cord contusion. Ann. Neurol. \n                           60, 540\u2013549 (2006).","journal-title":"Ann. Neurol."},{"key":"12449_CR21","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1089\/neu.2014.3355","volume":"31","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Human NgR-Fc Decoy Protein via Lumbar Intrathecal Bolus Administration Enhances Recovery from Rat Spinal Cord Contusion. J. Neurotrauma \n                           31, 1955\u20131966 (2014).","journal-title":"J. Neurotrauma"},{"key":"12449_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/ana.22527","volume":"70","author":"X Wang","year":"2011","unstructured":"Wang, X. et al. Recovery from chronic spinal cord contusion after nogo receptor intervention. Ann. Neurol. \n                           70, 805\u2013821 (2011).","journal-title":"Ann. Neurol."},{"key":"12449_CR23","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1523\/JNEUROSCI.6239-09.2010","volume":"30","author":"WBJ Cafferty","year":"2010","unstructured":"Cafferty, W. B. J., Duffy, P., Huebner, E. & Strittmatter, S. M. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J. Neurosci. \n                           30, 6825\u20136837 (2010).","journal-title":"J. Neurosci."},{"key":"12449_CR24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1126\/science.1204144","volume":"333","author":"Y Sato","year":"2011","unstructured":"Sato, Y. et al. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science \n                           333, 769\u2013773 (2011).","journal-title":"Science"},{"key":"12449_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.bbrc.2012.01.033","volume":"418","author":"Y Kurihara","year":"2012","unstructured":"Kurihara, Y. et al. The carboxyl-terminal region of Crtac1B\/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1. Biochem. Biophys. Res. Commun. \n                           418, 390\u2013395 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12449_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mcn.2014.07.001","volume":"61","author":"Y Kurihara","year":"2014","unstructured":"Kurihara, Y. et al. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand. Mol. Cell. Neurosci. \n                           61, 211\u20138 (2014).","journal-title":"Mol. Cell. Neurosci."},{"key":"12449_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/neu.2006.23.635","volume":"23","author":"DM Basso","year":"2006","unstructured":"Basso, D. M. et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma \n                           23, 635\u2013659 (2006).","journal-title":"J. Neurotrauma"},{"key":"12449_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/ALN.0b013e318173f66b","volume":"108","author":"Q Wang","year":"2008","unstructured":"Wang, Q. et al. Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology \n                           108, 1071\u20131080 (2008).","journal-title":"Anesthesiology"},{"key":"12449_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3613","volume":"72","author":"K Takahashi","year":"2015","unstructured":"Takahashi, K. et al. Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis. JAMA Neurol. \n                           72, 176 (2015).","journal-title":"JAMA Neurol."},{"key":"12449_CR30","first-page":"489","volume":"37","author":"P Peinado-Ram\u00f3n","year":"1996","unstructured":"Peinado-Ram\u00f3n, P. et al. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Iovs \n                           37, 489\u2013500 (1996).","journal-title":"Iovs"},{"key":"12449_CR31","first-page":"1357","volume":"56","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Effectglion cells in glaucoma models. Iovs \n                           56, 1357\u201366 (2015).","journal-title":"Iovs"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12449-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:17:11Z","timestamp":1671794231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12449-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12449"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12449-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]},"assertion":[{"value":"22 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M.S. is a co-founder of Axerion Therapeutics (New Haven, CT, USA), which is seeking to develop PrP- and NgR1-based therapeutics for neurological disease.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12119"}}